|
ABCF2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.408000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.852800E-01 |
| Normal-vs-Stage2 |
5.232000E-02 |
| Normal-vs-Stage3 |
3.719600E-01 |
| Normal-vs-Stage4 |
3.275600E-01 |
| Stage1-vs-Stage2 |
1.116160E-01 |
| Stage1-vs-Stage3 |
8.081200E-01 |
| Stage1-vs-Stage4 |
7.292800E-01 |
| Stage2-vs-Stage3 |
1.584630E-01 |
| Stage2-vs-Stage4 |
2.502800E-01 |
| Stage3-vs-Stage4 |
8.959000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.786770E-01 |
| Normal-vs-AfricanAmerican |
2.143400E-01 |
| Normal-vs-Asian |
6.608800E-01 |
| Caucasian-vs-AfricanAmerican |
7.739200E-01 |
| Caucasian-vs-Asian |
4.457400E-01 |
| AfricanAmerican-vs-Asian |
4.080400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.002000E-01 |
| Normal-vs-Female |
1.384380E-01 |
| Male-vs-Female |
9.460000E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.594400E-01 |
| Normal-vs-Age(41-60Yrs) |
4.065800E-01 |
| Normal-vs-Age(61-80Yrs) |
1.168170E-01 |
| Normal-vs-Age(81-100Yrs) |
1.914420E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.680800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.180200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.887400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.211800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.266200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.621000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.202400E-01 |
| Classical-VS-Follicular |
2.562300E-03 |
| Classical-VS-Other |
1.659530E-02 |
| Classical-VS-Normal |
3.265800E-02 |
| Tall-VS-Follicular |
2.963000E-01 |
| Tall-VS-Other |
7.327700E-02 |
| Tall-VS-Normal |
5.342200E-01 |
| Follicular-VS-Other |
3.529800E-01 |
| Follicular-VS-Normal |
5.203400E-01 |
| Other-VS-Normal |
1.369360E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.082000E-01 |
| Normal-vs-N1 |
7.896000E-01 |
| N0-vs-N1 |
2.664800E-01 |
|
|
